Healthcare provider profile · identity verified

Philip Michael Denoux, M.D.

Internal Medicine · NEW ORLEANS, LA · NPI 1588008213

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	171	54
Atorvastatin Calcium	Atorvastatin Calcium	152	50
Amlodipine Besylate	Amlodipine Besylate	139	40
Pantoprazole Sodium	Pantoprazole Sodium	99	35
Levothyroxine Sodium	Levothyroxine Sodium	90	29
Losartan Potassium	Losartan Potassium	90	30
Tamsulosin Hcl	Tamsulosin Hcl	83	28
Eliquis	Apixaban	82	22
Zolpidem Tartrate	Zolpidem Tartrate	68	16
Ezetimibe	Ezetimibe	58	16
Metoprolol Succinate	Metoprolol Succinate	57	22
Doxycycline Hyclate	Doxycycline Hyclate	56	51
Celecoxib	Celecoxib	55	21
Mounjaro	Tirzepatide	52	suppressed
Metformin Hcl	Metformin Hcl	51	13
Allopurinol	Allopurinol	47	12
Sertraline Hcl	Sertraline Hcl	46	11
Ozempic	Semaglutide	43	suppressed
Azithromycin	Azithromycin	42	35
Alprazolam	Alprazolam	41	14
Myrbetriq	Mirabegron	41	11
Gabapentin	Gabapentin	39	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Omeprazole	Omeprazole	34	suppressed
Prednisone	Prednisone	30	16
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	13
Fluticasone Propionate	Fluticasone Propionate	28	15
Lisinopril	Lisinopril	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	26	11
Irbesartan	Irbesartan	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Furosemide	Furosemide	25	11
Ondansetron Odt	Ondansetron	23	18
Tramadol Hcl	Tramadol Hcl	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Carvedilol	Carvedilol	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Zaleplon	Zaleplon	22	suppressed
Tradjenta	Linagliptin	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Valsartan	Valsartan	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	13
Entresto	Sacubitril/Valsartan	20	suppressed
Finasteride	Finasteride	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	17
Valacyclovir	Valacyclovir Hcl	19	suppressed
Famotidine	Famotidine	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Simvastatin	Simvastatin	15	suppressed
Temazepam	Temazepam	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Buspirone Hcl	Buspirone Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Atenolol	Atenolol	11	suppressed
Dovato	Dolutegravir Sodium/Lamivudine	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Gemtesa	Vibegron	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Lactulose	Lactulose	11	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error